Plasmodium vivax in India

Joshi, Hema; Prajapati, Surendra Kumar; Verma, Anju; Kang'a, S.; Carlton, Jane M.

doi:10.1016/j.pt.2008.01.007

Cited by 66 publications

(63 citation statements)

References 59 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The use of different molecular markers led to the detection of widely variable proportions of multiple-clone P. vivax infections worldwide (Table) (Joshi et al 2008). In general, multilocus analysis, such as microsatellite genotyping, detected greater numbers of multiple-clone infections when compared to single-locus analysis.…”

Section: Prevalence and Consequences Of Multiple-clone P Vivax Infecmentioning

confidence: 99%

A closer look at multiple-clone Plasmodium vivax infections: detection methods, prevalence and consequences

Havryliuk

Ferreira

2009

Mem. Inst. Oswaldo Cruz

View full text Add to dashboard Cite

Section: Prevalence and Consequences Of Multiple-clone P Vivax Infecmentioning

confidence: 99%

A closer look at multiple-clone Plasmodium vivax infections: detection methods, prevalence and consequences

Havryliuk

Ferreira

2009

Mem. Inst. Oswaldo Cruz

View full text Add to dashboard Cite

“…4 Mapping the local and global population structure of P. vivax is essential both before and after the rollout of intervention measures and when establishing goals for elimination, 5,6 as parasite populations can differ widely between locations due to vector prevalence, host genetics, and a variety of environmental factors. [7][8][9][10] Population genetic surveys to determine the diversity of P. vivax parasites within a given human population can reveal insights into the potential resilience of the parasite population to interventions.…”

Section: Introductionmentioning

confidence: 99%

High Genetic Diversity of Plasmodium vivax on the North Coast of Papua New Guinea

Arnott

Barnadas

Senn

et al. 2013

The American Journal of Tropical Medicine and Hygiene

View full text Add to dashboard Cite

Abstract. Despite having the highest Plasmodium vivax burden in the world, molecular epidemiological data from Papua New Guinea (PNG) for this parasite remain limited. To investigate the molecular epidemiology of P. vivax in PNG, 574 isolates collected from four catchment sites in East Sepik (N = 1) and Madang (N = 3) Provinces were genotyped using the markers MS16 and msp1F3. Genetic diversity and prevalence of P. vivax was determined for all sites. Despite a P. vivax infection prevalence in the East Sepik (15%) catchments less than one-half the prevalence of the Madang catchments (27-35%), genetic diversity was similarly high in all populations (H e = 0.77-0.98). High genetic diversity, despite a marked difference in infection prevalence, suggests a large reservoir of diversity in P. vivax populations of PNG. Significant reductions in transmission intensity may, therefore, be required to reduce the diversity of parasite populations in highly endemic countries such as PNG.

show abstract

“…P. vivax can result in relapse with varying clinical profile and drug response between patients. 1 The patient had received treatment for malaria, but no radical treatment which might have caused relapse of P. vivax. Though we could not confirm, but strongly feel that the relapse of malaria was responsible for the symptoms of lower motor neuron palsy.…”

Section: Discussionmentioning

confidence: 99%

“…P. vivax malaria in India is more prevalent than plasmodium falciparum. 1 In India P. vivax and P. falciparum accounts for about 60-65% and 35% cases respectively. 2 P. vivax is often thought to be benign infection; however, it may sometime result in severe complications affecting different organs.…”

Section: Introductionmentioning

confidence: 99%

Bilateral Facial Palsy: Post Vivax Malaria Scenario

Sawardekar¹,

Patil²,

Badgujar³

et al. 2016

jemds

View full text Add to dashboard Cite

Malaria can cause severe complications, sometimes affecting central nervous system. Cranial nerve palsies are rare after malaria. Plasmodium vivax malaria, often thought to be a benign disease can sometime lead to severe complications. We report a case of lower motor neuron palsy after plasmodium vivax malaria. KEYWORDSFacial Palsy, Vivax Malaria. HOW TO CITE THIS ARTICLE: INTRODUCTIONMalaria is a common health problem in tropical countries like India. Of the four plasmodium species causing malaria in humans, P. vivax is the most widespread. P. vivax malaria in India is more prevalent than plasmodium falciparum. 1 In India P. vivax and P. falciparum accounts for about 60-65% and 35% cases respectively. 2 P. vivax is often thought to be benign infection; however, it may sometime result in severe complications affecting different organs. 3 Commonly reported severe complications of P. vivax malaria include haematological problems, such as anaemia and thrombocytopenia, liver or kidney dysfunction, lung related complications, hypoglycaemia, shock and cerebral malaria. 2,3 We report here an unusual case of bilateral lower motor neuron palsy after P. vivax malaria.

show abstract

Plasmodium vivax in India

Cited by 66 publications

References 59 publications

A closer look at multiple-clone Plasmodium vivax infections: detection methods, prevalence and consequences

A closer look at multiple-clone Plasmodium vivax infections: detection methods, prevalence and consequences

High Genetic Diversity of Plasmodium vivax on the North Coast of Papua New Guinea

Bilateral Facial Palsy: Post Vivax Malaria Scenario

Contact Info

Product

Resources

About